Tags : ~$576M

Merck Acquires Calporta Therapeutics for ~$576M

Shots: Merck acquired Calporta, in the all-cash transaction making a total deal value ~$576M including an up front payment and contingent milestone payments The focus of the collaboration is to gain a preclinical portfolio of small-molecule TRPML1 agonists which are being evaluated for lysosomal storage and neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease Avalon Ventures […]Read More